首页> 外文期刊>Journal of Translational Medicine >Prevalence of the GJB2 IVS1+1G >A mutation in Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2
【24h】

Prevalence of the GJB2 IVS1+1G >A mutation in Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2

机译:GJB2编码区单等位基因致病性突变的中国听力损失患者中GJB2 IVS1 + 1G> A突变的患病率

获取原文
           

摘要

Background Mutations in the GJB2 gene are the most common cause of nonsyndromic recessive hearing loss in China. In about 6% of Chinese patients with severe to profound sensorineural hearing impairment, only monoallelic GJB2 mutations known to be either recessive or of unclear pathogenicity have been identified. This paper reports the prevalence of the GJB2 IVS1+1G>A mutation in a population of Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2. Methods Two hundred and twelve patients, screened from 7133 cases of nonsyndromic hearing loss in China, with monoallelic mutation (mainly frameshift and nonsense mutation) in the coding region of GJB2 were examined for the GJB2 IVS1+1G>A mutation and mutations in the promoter region of this gene. Two hundred and sixty-two nonsyndromic hearing loss patients without GJB2 mutation and 105 controls with normal hearing were also tested for the GJB2 IVS1+1G>A mutation by sequencing. Results Four patients with monoallelic mutation in the coding region of GJB2 were found carrying the GJB2 IVS1+1G>A mutation on the opposite allele. One patient with the GJB2 c.235delC mutation carried one variant, -3175 C>T, in exon 1 of GJB2. Neither GJB2 IVS1+1G>A mutation nor any variant in exon 1 of GJB2 was found in the 262 nonsyndromic hearing loss patients without GJB2 mutation or in the 105 normal hearing controls. Conclusion Testing for the GJB2 IVS 1+1 G to A mutation explained deafness in 1.89% of Chinese GJB2 monoallelic patients, and it should be included in routine testing of patients with GJB2 monoallelic pathogenic mutation.
机译:背景GJB2基因突变是中国非综合征性隐性听力损失的最常见原因。在约6%的中国患有严重至严重的感觉神经性听力障碍的患者中,仅鉴定出已知为隐性或致病性尚不清楚的单等位基因GJB2突变。本文报道了在GJB2编码区单等位基因致病突变的中国听力损失患者人群中,GJB2 IVS1 + 1G> A突变的患病率。方法从中国7133例非综合征性听力损失患者中筛选出122例GJB2编码区存在单等位基因突变(主要是移码和无义突变)的GJB2 IVS1 + 1G> A突变和启动子突变该基因的区域。还通过测序测试了262例无GJB2突变的非综合征性听力损失患者和105例听力正常的对照者的GJB2 IVS1 + 1G> A突变。结果发现4例在GJB2编码区发生单等位基因突变的患者在相对等位基因上携带GJB2 IVS1 + 1G> A突变。一名患有GJB2 c.235delC突变的患者在GJB2的外显子1中携带一种变体-3175 C> T。在262名无GJB2突变的非综合征性听力损失患者或105名正常听力对照者中,均未发现GJB2 IVS1 + 1G> A突变或GJB2外显子1的任何变异。结论检测GJB2 IVS 1 + 1 G到A突变可解释1.89%的中国GJB2单等位基因患者耳聋,应将其包括在GJB2单等位基因致病突变患者的常规检查中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号